Rankings
▼
Calendar
IMA Q3 2020 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena
IMA
ImageneBio Inc
$69M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
Gross Profit
-$4M
-155.1% margin
Operating Income
-$6M
-220.3% margin
Net Income
-$6M
-219.9% margin
EPS (Diluted)
$-0.44
QoQ Revenue Growth
-7.9%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$418,000
Balance Sheet
Total Assets
$61M
Total Liabilities
$60M
Stockholders' Equity
$367,000
Cash & Equivalents
$56M
← FY 2020
All Quarters
Q4 2020 →
